Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Almirall launches Actikerall in U.K. for treatment of actinic keratosis

June 8, 2011

Novel lactam tachykinin receptor antagonists presented

June 2, 2011

Leo Pharma begins phase II trial of LEO-90100 cutaneous spray ointment for psoriasis

May 31, 2011

Halozyme Therapeutics presents recombinant human proteins with collagenolytic effects

May 30, 2011

Phase II extension data encouraging for Derma Sciences' DSC-127 in diabetes-related foot ulcers

May 27, 2011

Merck & Co. patents novel glucocorticoid receptor modulators

May 26, 2011

Provectus Pharmaceuticals completes accrual in phase IIc PH-10 trial in psoriasis

May 25, 2011

Anacor initiates dosing in phase II trial of AN-2728 and AN-2898 in atopic dermatitis

May 18, 2011

Phase II trial compares topical mechlorethamine formulations in mycosis fungoides

May 16, 2011

Fibrotech Therapeutics presents novel antifibrotic compounds

May 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....